SG Americas Securities
LNAI

SG Americas Securities’s Lunai Bioworks LNAI Stock Holding History

SG Americas Securities’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-320
Closed -$7K – 3534
2025
Q2 		$7K Sell
320
-144
-31% -$4.02K ﹤0.01% 2864
2025
Q1 		$20K Sell
464
-183
-28% -$11.7K ﹤0.01% 3380
2024
Q4 		$43K Buy
647
+427
+194% +$28.3K ﹤0.01% 2933
2024
Q3 		$9K Buy
+220
New +$15.3K ﹤0.01% 3376
2024
Q2 		– Sell
-216
Closed -$46K – 3236
2024
Q1 		$46K Buy
+216
New +$58.3K ﹤0.01% 2781

Other funds holding LNAI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SG Americas Securities's LNAI Position: Q3 2025 in Review

SG Americas Securities sold out of Lunai Bioworks (LNAI) in Q3 2025, closing a stake of 320 shares — an estimated $7K sold.

SG Americas Securities first reported a position in LNAI in Q1 2024 and held it in 5 quarters. The position peaked at $46K in Q1 2024. 20 funds tracked by Wall St. Rank hold LNAI as of Q3 2025.

  • SG Americas Securities reported no remaining Lunai Bioworks position as of Q3 2025 after selling out during the quarter.
  • SG Americas Securities sold 320 Lunai Bioworks shares in Q3 2025, an estimated $7K.
  • SG Americas Securities first reported a position in Lunai Bioworks in Q1 2024 and held it in 5 quarters.
  • SG Americas Securities's Lunai Bioworks position peaked at $46K in Q1 2024.
  • 20 funds tracked by Wall St. Rank held Lunai Bioworks as of Q3 2025.

Based on SG Americas Securities's 13F filing for Q3 2025, filed 23 Oct 2025.